Outcomes for Recurrent Mantle Cell Lymphoma post-Ibrutinib Therapy: A Retrospective Cohort Study from a Japanese Administrative Database
Article full text
The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.
The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2022.